| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director, 10% Owner | 10% Owner | Director
7 companies
New Enterprise Associates 15, L.P. serves as a 10% Owner at IONQ and has filed Form 4s across 7 companies. Across recent SEC filings that breaks down to 4 buys and 4 sells. Those positions are worth an estimated $124.0M at current prices.
Historically, New Enterprise Associates 15, L.P.'s trades have earned a below-average insider score of 43/100 across 6 rated trades. Over a 12-month horizon, 33.3% of those trades were profitable, with an average 12-month return of -22.0%.
The biggest single holding is OKUR (~$71.8M) as 10% Owner. Net of sales, the recent Form 4 record there shows accumulation of 666,666 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 2, 2025 | NEUE Neuehealth, Inc. | Director, 10% Owner | Sale+OE | 280 | $6.75 | $1,890.00 | - | - | - | |
| Jun 21, 2022 | ACLX Arcellx, Inc. | 10% Owner | Buy | 312,500 | $16.00 | $5,000,000.00 | +4.9% | +19.4% | +108.1% | |
| May 31, 2022 | IONQ Ionq, Inc. | 10% Owner | Sell | 2,922,966 | $5.84 | $17,073,458.62 | -10.0% | +7.7% | +87.7% | |
| Feb 8, 2022 | ACLX Arcellx, Inc. | 10% Owner | Buy | 1,583,333 | $15.00 | $23,749,995.00 | +32.6% | -52.0% | +75.2% | |
| Apr 13, 2021 | OKUR Onkure Therapeutics, Inc. | 10% Owner | Buy | 666,666 | $15.00 | $9,999,990.00 | +16.2% | -26.7% | -77.4% | |
| Jul 14, 2020 | NKTX Nkarta, Inc. | 10% Owner | Buy | 666,666 | $18.00 | $11,999,988.00 | +29.8% | - | - |